Project Grant R01DK143997
- Federal Grant Award Summary Children's Hospital Los Angeles received a $141,087 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective September 30, 2025 through April 30, 2027. The award supports basic biomedical research investigating the role of the NGN3 protein in Notch signaling repression during pancreatic endocrinogenesis, with direct...
- Federal Project Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded $151,448 to the University of California, Davis on May 15, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to develop and pilot test a patient-centered virtual intervention addressing the critical healthcare transition period for adolescents and young adults (AYAs) with Type 1 Diabetes (T1D). The research applies...
- Federal Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded The Nemours Foundation $114,000 under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) on May 12, 2026, with a completion date of April 30, 2028. This Project Grant funds the development of provider-focused dissemination strategies for evidence-based psychosocial care in Type 1 Diabetes (T1D) treatment. The research team will conduct a...
- Federal Project Grant Award Summary The Children's Hospital of Philadelphia Research Institute received a $159,288 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective February 1, 2026 through January 31, 2031. This research award supports an investigator-initiated project designed to elucidate the pathogenic role of Interleukin-22 (IL-22) in...
- Federal Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded The Children's Hospital of Philadelphia Research Institute a $343,278 Project Grant effective July 16, 2025, through March 31, 2030, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). This award supports a multi-omic investigation of uremic toxin sources and accumulation in children with kidney failure, addressing the high morbidity and...
- Federal Project Grant Award Summary The Children's Hospital of Philadelphia Research Institute received a $133,500 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective May 5, 2026, through February 28, 2028. The research focuses on investigating the chromatin remodeler CHD7 as a regulator of hemoglobin expression, specifically examining the...
- Federal Grant Award Summary The Children's Hospital of Philadelphia Research Institute received a $796,742 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective February 6, 2026, with completion targeted for December 31, 2029. The grant funds research to develop urinary peptidomics biomarkers for risk stratification in patients with spina...
- Federal Project Grant Award Summary Boston Children's Hospital received a $168,543 Project Grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective May 1, 2026 through March 31, 2031. The award funds basic biomedical research investigating the mechanisms of hypothalamic-pituitary-adrenal (HPA) axis suppression and recovery following long-term glucocorticoid...
- Federal Grant Award Summary The Children's Hospital of Philadelphia Research Institute received a $949,759 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective May 15, 2026, through February 28, 2031. This award funds a real-world comparative effectiveness research study on membranous nephropathy (MN), an autoimmune glomerular disease causing...
- Federal Grant Award Summary The Jaeb Center for Health Research Foundation, Inc. received a $2.34M Project Grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), awarded September 3, 2025, with completion targeted for August 31, 2028. The award supports the COPILOT (Care Partner-Assisted Implementation of Patch Hybrid Closed Loop Insulin Delivery for Older Adults with...
The Children's Hospital of Philadelphia Research Institute received a $356,000 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective April 1, 2026 through March 31, 2029. This award funds the Partnering with Adolescents to Choose and Implement Technology in the Management of Type 1 Diabetes (PAC-IT) initiative, which develops and pilot tests a parent- and youth-directed behavioral intervention designed to increase adolescent decision-making involvement in the selection and implementation of automated insulin delivery (AID) systems. Delivered by trained health coaches, the intervention incorporates evidence-based components including education, goal setting, behavioral prompts, and structured parent-adolescent discussions grounded in social cognitive learning theory. The primary deliverables include refinement and pilot testing of the PAC-IT intervention to assess acceptability, barriers, and facilitators for promoting youth decision-making involvement regarding AID adoption. The research addresses the critical clinical challenge of declining AID use among children and adolescents despite the technology's proven clinical benefits, with the ultimate goal of facilitating consistent long-term AID utilization and improved type 1 diabetes health outcomes. This project responds to NIDDK's solicitation for small-scale clinical trials targeting diseases within the institute's mission.Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $356.0k | 4/28/26 |